Cabozantinib Impurity 9 CAS 18721-64-7

Purity 97%+In StockPharmaceutical Standards
CAS No.18721-64-7
Molecular FormulaC9H15BrO4
Molecular Weight267.12 g/mol
CategoryPharmaceutical Standards / API Standards
AvailabilityIn Stock

Chemical Structure

Cabozantinib Impurity 9 CAS 18721-64-7 chemical structure

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Cabozantinib Impurity 9.

CATO supplies Cabozantinib Impurity 9 (CAS 18721-64-7), a certified reference material (molecular formula C9H15BrO4, MW 267.12 g/mol) for analytical method development and quality control.

Based on its molecular formula C9H15BrO4, Cabozantinib Impurity 9 contains a carboxylic acid group, a hydroxyl group, an ether linkage, bromine substitution; these features give the compound characteristic functional-group stretching vibrations in infrared spectroscopy. The molecular weight of 267.12 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.

Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.

CATO manufactures Cabozantinib Impurity 9 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC9H15BrO4
Molecular Weight267.12 g/mol
Purity97%+
StorageStore in a cool place (≤25°C), keep sealed and dry, keep tightly closed to prevent evaporation
Solubility (reference)Soluble in methanol, ethanol, DMSO
StabilityHygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions
Degree of Unsaturation (DBE)2.0
CAS Registry Year (est.)1962
Halogen ContentBr-containing

Related Cabozantinib Standards

Recommended Standards

Why CATO?